Non-targeted metabolomics study for discovery of hepatocellular carcinoma serum diagnostic biomarker
Authors:
- 3 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 239, 115869
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81871932)
This publication has 52 references indexed in Scilit:
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- Quantitative LC–MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitorAnalytical Biochemistry, 2013
- Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseasesJournal of Inherited Metabolic Disease, 2012
- Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma DiagnosisMolecular & Cellular Proteomics, 2012
- Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular CarcinomaMolecular & Cellular Proteomics, 2011
- Lipid Profiles of Canine Invasive Transitional Cell Carcinoma of the Urinary Bladder and Adjacent Normal Tissue by Desorption Electrospray Ionization Imaging Mass SpectrometryAnalytical Chemistry, 2009
- Serum Metabolomics Reveals Irreversible Inhibition of Fatty Acid β-Oxidation through the Suppression of PPARα Activation as a Contributing Mechanism of Acetaminophen-Induced HepatotoxicityChemical Research in Toxicology, 2009
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Phytosphingosine induced mitochondria‐involved apoptosisCancer Science, 2005
- EFFECTS OFl-HISTIDINOL ON THE ANTITUMOUR ACTIVITY AND ACUTE CARDIOTOXICITY OF DOXORUBICIN IN MICEPharmacological Research, 1998